We identified 5 hub genes including HMMR, CCNB1, CXCL8, MAD2L1, and CCNA2 with poor prognosis in GC on the basis of integrated bioinformatical methods, which could be potential biomarkers and therapeutic targets for GC treatment. Here, CCNB1 is linked to gastric cancer.